HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human vitreous penetration of imipenem.

Abstract
The purpose of this study was to determine imipenem concentrations in vitreous humor of non-infected human eyes. Ten patients undergoing vitrectomy were infused with a single dose of either 0.5g (5 patients) or 1g (5 patients) of imipenem. Vitreous humor was withdrawn 2 or 4 hours after the end of the infusion. Results differed in relation to the dose. After 0.5g, vitreous levels were stable (approximately 0.20 mg/l), but after 1g they were significantly higher (approximately 2 mg/l). These levels were above the minimum inhibitory concentration of imipenem for 90% (MIC 90) of the main species responsible for endophthalmitis.
AuthorsJ P Adenis, M Mounier, J L Salomon, F Denis
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 1994 Apr-Jun Vol. 4 Issue 2 Pg. 115-7 ISSN: 1120-6721 [Print] United States
PMID7950335 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Imipenem
Topics
  • Aged
  • Humans
  • Imipenem (administration & dosage, pharmacokinetics)
  • Infusions, Intravenous
  • Vitrectomy
  • Vitreous Body (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: